Cargando…

Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa

The distinction between metastasis from a colorectal adenocarcinoma into the ovary and an ovarian adenocarcinoma is vital, but challenging at times, due to overlapping morphological features. Similarly, a distinction between an ovarian metastasis into the colorectum and a colorectal adenocarcinoma,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rekhi, Bharat, George, Sophia, Madur, Bhulaxmi, Chinoy, RF, Dikshit, Rajesh, Maheshwari, Amita
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556647/
https://www.ncbi.nlm.nih.gov/pubmed/18801162
http://dx.doi.org/10.1186/1746-1596-3-39
_version_ 1782159576611684352
author Rekhi, Bharat
George, Sophia
Madur, Bhulaxmi
Chinoy, RF
Dikshit, Rajesh
Maheshwari, Amita
author_facet Rekhi, Bharat
George, Sophia
Madur, Bhulaxmi
Chinoy, RF
Dikshit, Rajesh
Maheshwari, Amita
author_sort Rekhi, Bharat
collection PubMed
description The distinction between metastasis from a colorectal adenocarcinoma into the ovary and an ovarian adenocarcinoma is vital, but challenging at times, due to overlapping morphological features. Similarly, a distinction between an ovarian metastasis into the colorectum and a colorectal adenocarcinoma, although rare; is important and can be daunting. We report an analysis of 20 cases of ovarian involvement by metastatic colorectal adenocarcinomas and colorectal involvement by metastatic ovarian adenocarcinomas, including the value of differential expression of cytokeratins 7 & 20 by immunohistochemistry (IHC), in these cases. Nine cases (45%) were identified as colorectal adenocarcinomas metastatic to the ovary. On biopsy, all these cases showed a 'garland-like' tumor necrosis, with desmoplasia and predominantly exhibited a tubuloalveolar pattern (67% cases). On IHC, all 8 of 9 such cases, where staining for cytokeratin 20 was performed, displayed strong positivity and 7 cases, where staining for carcinoembryogenic antigen (CEA) was performed, revealed positivity for this marker (100%). Other 11 cases (55%) were ovarian adenocarcinomas, metastatic to the colorectum. These showed metachronous presentations, with the ovarian tumor preceding the colorectal tumor deposits. Morphologically, psammomatous calcification was noted in 73% of these cases, whereas 'garland-like' necrosis was absent in all. The chief morphological subtype was serous papillary cystadenocarcinoma (55% cases). On IHC, CK7 and CA 125 were positive in all 6 of 11 such cases, whereas CK 20 was negative in all these cases. In cases of complex presentations like an ovarian involvement by a metastatic colorectal adenocarcinoma and vice-versa, certain clinicopathological features are useful. Differential expression of CK 7 and CK20 is vital in resolving these dilemmas. CK20 positivity and CK7 negativity is associated with a colorectal adenocarcinoma. Markers like CEA and CA-125 have an added value.
format Text
id pubmed-2556647
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25566472008-10-01 Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa Rekhi, Bharat George, Sophia Madur, Bhulaxmi Chinoy, RF Dikshit, Rajesh Maheshwari, Amita Diagn Pathol Software The distinction between metastasis from a colorectal adenocarcinoma into the ovary and an ovarian adenocarcinoma is vital, but challenging at times, due to overlapping morphological features. Similarly, a distinction between an ovarian metastasis into the colorectum and a colorectal adenocarcinoma, although rare; is important and can be daunting. We report an analysis of 20 cases of ovarian involvement by metastatic colorectal adenocarcinomas and colorectal involvement by metastatic ovarian adenocarcinomas, including the value of differential expression of cytokeratins 7 & 20 by immunohistochemistry (IHC), in these cases. Nine cases (45%) were identified as colorectal adenocarcinomas metastatic to the ovary. On biopsy, all these cases showed a 'garland-like' tumor necrosis, with desmoplasia and predominantly exhibited a tubuloalveolar pattern (67% cases). On IHC, all 8 of 9 such cases, where staining for cytokeratin 20 was performed, displayed strong positivity and 7 cases, where staining for carcinoembryogenic antigen (CEA) was performed, revealed positivity for this marker (100%). Other 11 cases (55%) were ovarian adenocarcinomas, metastatic to the colorectum. These showed metachronous presentations, with the ovarian tumor preceding the colorectal tumor deposits. Morphologically, psammomatous calcification was noted in 73% of these cases, whereas 'garland-like' necrosis was absent in all. The chief morphological subtype was serous papillary cystadenocarcinoma (55% cases). On IHC, CK7 and CA 125 were positive in all 6 of 11 such cases, whereas CK 20 was negative in all these cases. In cases of complex presentations like an ovarian involvement by a metastatic colorectal adenocarcinoma and vice-versa, certain clinicopathological features are useful. Differential expression of CK 7 and CK20 is vital in resolving these dilemmas. CK20 positivity and CK7 negativity is associated with a colorectal adenocarcinoma. Markers like CEA and CA-125 have an added value. BioMed Central 2008-09-18 /pmc/articles/PMC2556647/ /pubmed/18801162 http://dx.doi.org/10.1186/1746-1596-3-39 Text en Copyright © 2008 Rekhi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Software
Rekhi, Bharat
George, Sophia
Madur, Bhulaxmi
Chinoy, RF
Dikshit, Rajesh
Maheshwari, Amita
Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
title Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
title_full Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
title_fullStr Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
title_full_unstemmed Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
title_short Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
title_sort clinicopathological features and the value of differential cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556647/
https://www.ncbi.nlm.nih.gov/pubmed/18801162
http://dx.doi.org/10.1186/1746-1596-3-39
work_keys_str_mv AT rekhibharat clinicopathologicalfeaturesandthevalueofdifferentialcytokeratin7and20expressioninresolvingdiagnosticdilemmasofovarianinvolvementbycolorectaladenocarcinomaandviceversa
AT georgesophia clinicopathologicalfeaturesandthevalueofdifferentialcytokeratin7and20expressioninresolvingdiagnosticdilemmasofovarianinvolvementbycolorectaladenocarcinomaandviceversa
AT madurbhulaxmi clinicopathologicalfeaturesandthevalueofdifferentialcytokeratin7and20expressioninresolvingdiagnosticdilemmasofovarianinvolvementbycolorectaladenocarcinomaandviceversa
AT chinoyrf clinicopathologicalfeaturesandthevalueofdifferentialcytokeratin7and20expressioninresolvingdiagnosticdilemmasofovarianinvolvementbycolorectaladenocarcinomaandviceversa
AT dikshitrajesh clinicopathologicalfeaturesandthevalueofdifferentialcytokeratin7and20expressioninresolvingdiagnosticdilemmasofovarianinvolvementbycolorectaladenocarcinomaandviceversa
AT maheshwariamita clinicopathologicalfeaturesandthevalueofdifferentialcytokeratin7and20expressioninresolvingdiagnosticdilemmasofovarianinvolvementbycolorectaladenocarcinomaandviceversa